WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 5'3001 Infant (under 12 months) mortality rate: 1002
GDP / capita (US$): 7'9101 Child (under 5 years) mortality rate: 1642

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 22'137  21'472  20'821  20'180  19'549  13'925  10'334  7'637 
Births 965  949  934  920  906  709  548  405 
Surviving infants 874  859  844  829  815  619  465  341 
Pop. less than 5 years 4'076  4'021  3'966  3'895  3'796  2'731  2'055  1'491 
Pop. less than 15 years 10'462  10'199  9'930  9'647  9'346  6'633  4'905  3'550 
Female 15-49 years 4'955  4'786  4'627  4'477  4'339  3'112  2'287  1'705 

Number of reported case

(Click for retrospective incidence data for Angola)
Diphtheria 20  15  64 
Japanese encephalitis
Measles 11'699  8'523  4'458  1'449  1'190  2'219  29'069  29'656 
Mumps
Pertussis 1'259  1'554  2'539  560  14'420  54'126 
Polio* 33  115  32 
Rubella 112  36  65  24  38 
Rubella (CRS)
Tetanus (neonatal) 19  33  75  13  131  959  541 
Tetanus (total)** 330  360  543  953  490  1'826  1'185 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Angola)
Vaccine year result method % card seen                                                
BCG 2000  69  MICS   34  81  85  87  88  93  56 
DTP1 2000  56  MICS   34  99  97  99*  99*  99*  44 
DTP3 2000  34  MICS   34  80  93  91  86  91  31 
DTP4         
IPV1          99* 
HepB_BD         
HepB3          80  93  91  86  91 
Hib3          80  93  91  86  91 
JapEnc         
MCV1          85  91  97  88  93 
MCV2         
PCV1          84  44 
PCV3          61 
Pol3 2000  63  MICS   34  81  80  88  85  92  33 
Rota1          34 
Rota_last          18 
Rubella1         
TT2plus 2000  62  MICS   34  76  83  78  79  87 
PAB         
VAD1          12  19  21  18  19 
YFV 1995  21  MICS   43  77  49  63  64  40  29 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Angola)
BCG 81  85  87  88  93  56  48 
DTP1 99  97  99  99  99  44  48 
DTP3 80  93  91  86  91  31  24 
HepB3 80  93  91  86  91 
HepB_BD
Hib3 80  93  91  86  91 
MCV1 85  91  97  88  93  41  38 
MCV2
PAB 78  75  72  70  75  60  34 
PCV3 61 
Pol3 81  80  88  85  92  33  23 
Rota_last 18 
YFV 77  49  63  64  40  50 

Number of districts in the country 166  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 39
From 80 to 89% 8
From 50 to 79% 37
Less than 50% 16
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes <1 year
DTwPHibHepB 2, 4, 6 months; Yes
IPV 6 months; From September 2015
Measles 9 months; Yes
OPV Birth; 2, 4, 6 months; Yes
Pneumo_conj 2, 4, 6 months; Yes
Rotavirus 2, 4 months; Yes From April 2014
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes CBAW
VitaminA 6, 9 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2011- 2015  2010-2015  2009 - 2012 
Nº of districts with microplans that include activities to raise immunization coverage number 155  157  123  120  79    160 

System performance

Total Nº districts in country number 166  166  165  164  164  164  164 
Nº districts with DTP3 coverage >=80% number 77  109  112  96  99  65  76 
% of districts with DTP3 coverage >=80% From 0 to 100% 46  66  68  59  60  40  46 
Nº districts with measles (MCV1) coverage >=95% number 71  99  87  74  81  53  53 
% of districts with MCV1 coverage >=95% From 0 to 100% 43  60  53  45  49  32  32 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  Yes  No  No  No  No  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%   88  90  90  34     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  Yes  Yes  Yes  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.